Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Government to benefit from training of interpreters
2009-03-31

 
Pictured, from the left, are: Prof Theo du Plessis (Director: Unit for Language Management, UFS), Ms Mokone Nthongoa (HOD: Sport, FS Department of Sport, Arts and Culture), Mr Khotso Sesele (MEC: FS Department of Sport, Arts and Culture) and Prof Engela Pretorius (Vice Dean: Faculty of the Humanities, UFS).
Photo: Mangaliso Radebe
Government to benefit from training of interpreters

The fourth phase of a project to train eight conference interpreters and 30 community interpreters to assist government departments at service delivery points in the Free State was launched this week.

The project is part of the Multilingualism Information Development Programme which brings together the Free State provincial government, the Province of Antwerp and the University of Antwerp in Belgium and the University of the Free State (UFS).

Speaking at the launch of the fourth phase of the project, the MEC for Sport, Arts and Culture in the Free State, Mr Khotso Sesele, said: “The fact that we have been through the first three stages of this project, and are now launching its fourth phase, is indicative of the magnificent progress that has been made. This is a sign that through partnerships we can achieve more.”

The MIDP IV consists of two pillars, namely a practical and a research component. Its aim is to generate interpreting capacity within the provincial Department of Sport, Arts and Culture. The focus is on training an interpreting team over three years which can be employed within a governmental context at various service points.

“As we approach the 2009 FIFA Confederation Cup and the 2010 FIFA World Cup tournaments, it will be important for our communities to be able to interact with millions of foreign nationals who will be in our country from different world destinations during and beyond these two important soccer events,” said the MEC.

“The focus on interpreter training by this fourth phase of MIDP is thus an important factor in ensuring better communication during and beyond these important soccer spectacles that will take place in our country.”
The focus of the first three phases of the MIDP was on the main official languages of the province. This fourth phase, which started in 2008, will run until 2010 and its focus is on the Xhariep District Municipality.

“The provision of interpreting services and its further extension to district municipalities will provide the necessary interpreting skills to our communities that will enhance better interaction amongst ourselves,” said Mr Sesele.

He said the fact that indigenous languages have been “elevated from their marginalised status to being languages of business and commerce” is an important milestone that must be cherished.

This fourth phase of MIDP will also incorporate sign language as part of its focus on interpreting services.

“In our quest to ensure a multilingual dispensation in our province, we need not neglect to remember people with disabilities,” he said. “This is a matter of principle that does not require debate.”

“We should thus ensure the realisation of the goal of MIDP IV which is to ensure smooth communication interaction within the wider public, including the deaf community.”

“This is a wonderful project,” said Ms Mathabo Monaheng, one of the students in the MIDP. “As a sign language interpreter trainee this project will empower me with the necessary skills to be able to make a meaningful contribution to the deaf community in terms of communication.”

The MIDP is funded by the Province of Antwerp and successfully implemented by the Unit for Language Management at the UFS.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za  
31 March 2009

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept